Adding serum sodium to model for end-stage liver disease: identifying those most at risk.
Crawford
Darrell H G
DH
Stuart
Katherine
K
D015415:Biomarkers / Q000097:blood; D003661:Decision Support Techniques; D018450:Disease Progression; D015536:Down-Regulation; D006305:Health Status Indicators; D006801:Humans; D007010:Hyponatremia / Q000097:blood / Q000209:etiology* / Q000401:mortality; D008103:Liver Cirrhosis / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000401:mortality / Q000601:surgery; D017093:Liver Failure / Q000097:blood / Q000209:etiology* / Q000401:mortality / Q000601:surgery; D016031:Liver Transplantation; D008954:Models, Biological; D018579:Patient Selection; D011237:Predictive Value of Tests; D011379:Prognosis; D015203:Reproducibility of Results; D018570:Risk Assessment; D012964:Sodium / Q000097:blood*
D015415:Biomarkers; D012964:Sodium